Theriva Biologics TOVX
NYSE TOVX
$0.19 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Theriva Biologics (TOVX) Net Debt Issuances and Repayments (2010 - 2026)

Updated

Analysis

Theriva Biologics (TOVX) Net Debt Issuances and Repayments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -4.36 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -2.00 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 64.00 Mn
10 Theriva Biologics 8.72 Mn -37.63 Mn - -11,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,000.00
Mar 31, 2026 -49,000.00
Dec 31, 2025 14,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 46,000.00
Mar 31, 2025 1.29 Mn
Jun 30, 2023 -20,000.00
Mar 31, 2023 -55,000.00
Mar 31, 2022 -1.38 Mn
Sep 30, 2010 -2,375.00
API Access

Theriva Biologics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=TOVX&period=max&api_key=YOUR_API_KEY